A comprehensive cancer care program in Northern California
UCDCCC NCTN UG1 PROGRAM
The UC Davis Comprehensive Cancer Center is offering patients the chance to try new and exciting cancer treatments through clinical trials, all while being supported by a team of experts dedicated to improving care and outcomes for everyone involved.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11250469 on NIH RePORTER |
What this research studies
The UC Davis Comprehensive Cancer Center (UCDCCC) provides essential cancer care and serves as a referral center for specialized cancer treatments in Northern California. This program focuses on enhancing clinical trials and research efforts across various cancer types, leveraging a multidisciplinary team of experts in oncology, molecular biology, and biostatistics. Patients may have access to innovative treatment options and participate in clinical trials that could lead to improved outcomes. The program also aims to foster career development for new researchers and healthcare professionals in the community.
Who could benefit from this research
Good fit: Ideal candidates include individuals diagnosed with various types of cancer who are seeking advanced treatment options and clinical trial participation.
Not a fit: Patients with non-cancerous conditions or those not residing in the Northern California area may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment options and better patient outcomes in the region.
How similar studies have performed: Previous research initiatives at UCDCCC and similar cancer centers have shown success in improving cancer care through clinical trials and multidisciplinary approaches.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Gandara, David R — University of California at Davis
- Study coordinator: Gandara, David R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.